Category Archives: News
Neurology: Placebo effect of medication cost in Parkinson disease – Expensive placebo’s effectiveness comparable to levodopa.
Although both placebos improved motor function, benefit was greater when patients were randomized first to expensive placebo, with a magnitude halfway between that of cheap placebo and levodopa. Brain activation was greater upon first-given cheap but not upon first-given expensive placebo or by levodopa. Regardless of order of administration, only cheap placebo increased activation in the left lateral sensorimotor cortex and other regions. Continue reading
Turmeric compound may treat Alzheimer’s disease
Research Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo Joerg Hucklenbroich12, Rebecca Klein23, Bernd Neumaier3, Rudolf Graf3, Gereon Rudolf Fink12, Michael Schroeter123 and Maria Adele Rueger123* *Corresponding author: Maria A Rueger adele.rueger@uk-koeln.de Author Affiliations 1Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich, Leo-Brandt-Straße 52425, Jülich, … Continue reading
Too much sitting around may kill you. Period.
Paleo-epidemiology. We were simply not designed to sit around a lot. Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults: A Systematic Review and Meta-analysis Aviroop Biswas, BSc; Paul I. Oh, MD, MSc; Guy E. … Continue reading
Treatment of vitamin D deficiency in asymptomatic persons might reduce mortality risk
20 January 2015, Vol 162, No. 2> Reviews | 20 January 2015 Screening for Vitamin D Deficiency: A Systematic Review for the U.S. Preventive Services Task Force Erin S. LeBlanc, MD, MPH; Bernadette Zakher, MBBS; Monica Daeges, BA; Miranda Pappas, MA; and Roger Chou, MD [+] … Continue reading
“Noncognitive” symptoms of early Alzheimer disease
Conclusions: We found a significantly earlier presence of positive symptoms on the NPI-Q in cognitively normal patients who subsequently developed CDR >0. Among participants with no depression symptoms at baseline, results suggest that depressive symptoms may increase with aging regardless of incipient dementia. Such findings begin to delineate the noncognitive course of Alzheimer disease dementia in the preclinical stages. Future research must further elucidate the correlation between noncognitive changes and distinct dementia subtypes. Continue reading
Maurice Preter, MD
Maurice Preter, MD is a European and U.S. educated psychiatrist, psychotherapist, psychopharmacologist, neurologist, and medical-legal expert in private practice in Manhattan. He is also the principal of Fifth Avenue Concierge Medicine, PLLC, a medical concierge service and health advisory for select individuals and families.